Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19COVID-19에 대한 지표 정규화된 비음성 매트릭스 분해 방법 기반 약물 용도 변경Immunology Published on 2021-01-292022-08-31 Journal: Frontiers in Immunology [Category] SARS, 신약개발, 치료제, [키워드] Algorithm analyzed approved drugs Area associations AUC biological networks characteristic COVID-19 COVID-19 infection Curve dataset de novo drug Drug discovery Drug repurposing drugs Efficacy Indicator Infectious disease Infectious diseases introduced matrix non-negative matrix factorization Novel coronavirus prevalent receiver operating characteristic reduce repurposing semi-supervised learning significantly suggested tested therapeutic drug Vaccine viruses [DOI] 10.3389/fimmu.2020.603615 PMC 바로가기 [Article Type] Immunology
Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics다이아몬드 광원: SARS-CoV-2 생물학 및 치료제에 대한 기여Article Published on 2021-01-292022-08-31 Journal: Biochemical and Biophysical Research Communication [Category] SARS, 신약개발, [키워드] Antibody structure Antiviral applied approach approved Biologicals clinically Coronaviruses COVID-19 Cryo-electron microscopy cryo-EM Crystallography develop diamond drug Drug discovery Drug repurposing drugs effective Fragment based drug discovery highly pathogenic LIGHT monoclonal antibody monoclonal antibody therapy NMR pandemic Protein public health released repurposing Research response Safe SARS-CoV-2 SARS-CoV-2 biology SARS-CoV-2 sequence sequence Source structural biology Structure-based drug design the SARS-CoV-2 therapy treat Treatment Vaccine Vaccine development [DOI] 10.1016/j.bbrc.2020.11.041 PMC 바로가기 [Article Type] Article
Drug repurposing improvement using a novel data integration framework based on the drug side effectResearch article Published on 2021-01-282022-10-05 Journal: Informatics in Medicine Unlocked [Category] 신약개발, [키워드] Accuracy addition Algorithm approved drugs association AUC Computational approaches costly criteria drug Drug repurposing Drug side effect drugs feature heterogeneous IMPROVE indicated indication Link prediction matrix factorization predict primary stage Research seeking Side effect time-consuming [DOI] 10.1016/j.imu.2021.100523 [Article Type] Research article
Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable TargetsSARS-CoV-2 약물 가능 표적을 인식하는 자연 발생 화합물에 대한 최신 업데이트Review Published on 2021-01-262022-09-10 Journal: Molecules [Category] MERS, 신약개발, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 approach approaches benzoquinones China clinical trial clinical trials Compound coronavirus COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 patients current data set drug Drug repurposing effective effort etiologic agent experimental evidence flavonoids Health in silico in vitro in vivo in-silico In-vitro inhibit investigated Medicine multi-targeting natural products Naturally outbreak Potential treatment Prevent recognizing recruited required Research respiratory SARS-CoV-2 SARS-COV-2 infection Scientific community severe acute respiratory syndrome Coronavirus Spread target targets therapeutic Transmissibility treat virus [DOI] 10.3390/molecules26030632 PMC 바로가기 [Article Type] Review
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2Pharmacology Published on 2021-01-252022-10-31 Journal: Frontiers in Pharmacology [Category] COVID-19, [키워드] against SARS-CoV anti-SARS-CoV-2 activities Anti-SARS-CoV-2 Activity antiviral activity approach approved approved drug approved drugs carried Chlorprothixene clinical trial Compound compounds COVID-19 cytopathic Cytopathic effect drug Drug repurposing drug repurposing and discovery drugs Ebola virus Effect FDA-approved drug HTS identify Infectious disease new drug combination Quantitative reported repurposing resource SARS-CoV-2 Screen Treatment [DOI] 10.3389/fphar.2020.592737 PMC 바로가기 [Article Type] Pharmacology
Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing ApproachArticle Published on 2021-01-252022-10-28 Journal: Pharmaceuticals [Category] COVID-19, [키워드] biological processe biosynthetic candidate caused cellular clinical trials Connectivity map COVID-19 COVID-19 pandemic dataset developmental processes Differentially expressed genes drug drug candidate drug candidates Drug repurposing enrichment analysis generate Health heterogeneous host cell host transcriptome identification identify Imatinib immune response Improvements include initial knowledge metabolic process outbreak pathway Pathways repurposing SARS-CoV-2 SARS-CoV-2 virus signaling pathways Study design Support transcriptomic transcriptomic alteration Treatment virus was performed [DOI] 10.3390/ph14020087 PMC 바로가기 [Article Type] Article
DrugRepV: a compendium of repurposed drugs and chemicals targeting epidemic and pandemic virusesArticle Published on 2021-01-222023-07-01 Journal: Briefings in Bioinformatics [Category] SARS, [키워드] Drug repurposing pandemics/epidemics SARS-CoV-2 viruses web server [DOI] 10.1093/bib/bbaa421 PMC 바로가기
In silico Analysis Revealed Potential Anti-SARS-CoV-2 Main Protease Activity by the Zonulin Inhibitor Larazotide AcetateChemistry Published on 2021-01-152022-10-31 Journal: Frontiers in Chemistry [Category] COVID-19, [키워드] activity acute lung injury acute respiratory distress airways ameliorated animal model anti-SARS-CoV-2 anti-viral activity ARDS binding Blood catalytic domain characterized co-crystallized Combined component conformational COVID-19 infection Drug repurposing Efficacy endothelial engage enzyme epithelial expand Gas exchange infected patient inhibitor Interaction interstitial pneumonia involved larazotide larazotide acetate lifecycle ligands Lungs M pro Mpro inhibitor MM-GBSA molecular molecular docking molecular dynamics Mortality motif Mouse models mucosal neutrophil outcome pandemic Pathogenesis Peptide inhibitor phase 3 trial plasma Potential profiles protease Protein reported Respiratory failure responsible resulting Revealed robust steric hindrance Structure subject subsequent syndrome the SARS-CoV-2 Treatment turn variety [DOI] 10.3389/fchem.2020.628609 PMC 바로가기 [Article Type] Chemistry
Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assaysArticle Published on 2021-01-142023-07-01 Journal: Methods (San Diego, Calif.) [Category] SARS, [키워드] 2′-O-MT, 2′-O-Methyltransferase 3CLpro enzymatic assay 3CLpro, 3-chymotrypsin-like protease anti-viral assay BIM IX, bisindolylmaleimide IX Bisindolylmaleimide (BIM) IX CAD, computer-aided drug design COACH, Meta-server approach to protein-ligand binding site prediction CoronaVirus Disease-2019 (COVID-19), SARS Corona Virus2 (SARS-CoV-2) COVID-19 Drug repurposing ExoN, exoribonuclease HTVS, high throughput virtual screening MD simulations MERS, Middle Eastern respiratory syndrome MM-GBSA MOA, mechanism of action NendoU, Nonstructural Uridylate-specific endoribonuclease PLpro, 3CLpro, RdRP, Helicase, ExoN, NendoU, and 2′-O-MT PLpro, Papain-like proteinase RdRP, RNA-directed RNA polymerase SARS-CoV-2 SARS, Severe acute respiratory syndrome Virtual screening [DOI] 10.1016/j.ymeth.2021.01.003 PMC 바로가기 [Article Type] Article
Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients혈액 전사체의 질병 중증도별 호중구 서명은 COVID-19 환자를 계층화합니다Research Published on 2021-01-132022-08-07 Journal: Genome Medicine [Category] 신약개발, 유전자 메커니즘, 진단, 치료제, [키워드] acute respiratory distress acute respiratory distress syndrome analyzed Asymptomatic available data blood cell blood transcriptome Blood transcriptomics capture Cell changes in clinical Clinical parameters Clinical presentations Co-expression analysis Cohort Combination control sample COVID-19 COVID-19 patient data-driven death disease severity dissect Donor driver drug candidate drug candidates targeting Drug repurposing drug target dysregulated explained granulocyte granulocyte sample Granulocytes groups Host host responses identify immune immune system independent Infection Inflammatory diseases Mild mild respiratory mild respiratory tract infection Molecular disease phenotypes molecular phenotype molecular subgroup neutrophil neutrophil activation Neutrophil activation-associated signature Neutrophils other diseases parameters Patient performed phenotype Phenotypes predicted provide report respiratory respiratory distress Respiratory failure respiratory tract infection Result RNA-Seq SARS-CoV-2 pandemic Severe case severe cases severe COVID-19 patient Severe patient Stratification stratified supplementary material syndrome systemic immune response Transcriptome transcriptomes Viral viral infections was used Whole blood whole blood transcriptome PMC 바로가기 [Article Type] Research